Add time:09/10/2019 Source:sciencedirect.com
The response to cis-dichlorobis(cyclopentylamine)platinum(II) (cis-PAD) an antitumour platinum complex, was studied in two strains of murine lymphoma L5178Y cross-sensitive to X-rays and UV light. Dose-survival relationship, DNA synthesis, formation of chromatid aberrations, progression through the cell cycle, and growth and viability changes after 1 h cis-PAD treatment at 37°C were examined and compared with the effects of X-rays and UV light.In both strains, cis-PAD caused immediate inhibition of progression through the cell cycle, reduced rate of DNA synthesis, delayed appearance of chromatid aberrations, and delayed death; however, there is a marked difference in sensitivity to cis-PAD between L5178Y-S strain Do approx. 5.8 μg/ml and L5178Y-R strain (D0) approx. 2.5 μg/ml. In both strains a close resemblance was found between dose-survival relationships after cis-PAD and UV light treatment, respectively.
We also recommend Trading Suppliers and Manufacturers of N,N-Dimethyl Cyclopentylamine (cas 18636-91-4). Pls Click Website Link as below: cas 18636-91-4 suppliers
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View